Raithel Martin, Kluger Anna Katharina, Dietz Birgit, Hetterich Urban
Gastroenterologie, Interventionelle Endoskopie, Hämato-Onkologie, Diabetes- und Stoffwechselerkrankungen Waldkrankenhaus St. Marien gGmbH, Rathsberger Str. 57, 91054, Erlangen, Deutschland.
Diätberatung Universität Erlangen, Erlangen, Deutschland.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Jul;59(7):821-6. doi: 10.1007/s00103-016-2366-z.
The avoidance of wheat, gluten and other cereal products is a growing phenomenon in industrialized countries. The diagnostic criteria of celiac disease and of food allergy to wheat flour and/or other cereals are clearly defined. Only about 0.5-25 % of the population are affected from both of these immunological diseases.Nevertheless, there exists a significantly greater proportion of people reporting at least subjectively significant complaints and quality of life improvements after switching to a wheat- or gluten-free diet. Celiac disease or wheat allergy cannot be detected in these individuals on the basis of established criteria. The absence of clear diagnostic autoimmune or allergic criteria in these wheat sensitive patients has resulted in the description of non-celiac gluten sensitivity.It is clinically detectable in only very few individuals and may manifest with either intestinal, extra-intestinal or neurovegetative and psychosomatic symptoms, respectively. However, non-celiac disease gluten sensitivity has to be differentiated critically from irritable bowel syndrome, carbohydrate malassimilation, postinfectious conditions and psychosomatic diseases.Pathophysiologically, non-celiac disease gluten sensitivity is still poorly characterized; several non-immunological mechanisms are discussed to contribute to non-celiac gluten sensitivity. These include the effects of fructo- and galacto-oligosaccharides, of trypsin inhibitors of amylase, and wheat lectin agglutinins, which may influence or modulate intestinal permeability and/or a non-specific immune or effector cell degranulation within the gastrointestinal tract. In addition, further metabolic effects with direct or indirect influence on the intestinal flora are currently discussed.In addition to subjectively reported changes in symptoms that may affect variably intestinal, as well as extra-intestinal and/or neuropsychiatric symptoms, some studies suggest that there is little reproducibility of complaints from gluten exposure. For a definitive diagnosis of non-celiac gluten sensitivity, structured (blinded) challenge tests with wheat or gluten are mandatory as well as re-challenge after a defined time of gluten avoidance to establish non-celiac disease gluten sensitivity as a persistent disease entity.
在工业化国家,避免食用小麦、麸质及其他谷物产品的现象日益普遍。乳糜泻以及对小麦粉和/或其他谷物的食物过敏的诊断标准已明确界定。只有约0.5%-25%的人口受这两种免疫性疾病影响。然而,有相当大比例的人报告称,在改用无小麦或无麸质饮食后,至少主观上有明显不适症状减轻且生活质量有所改善。根据既定标准,在这些个体中无法检测出乳糜泻或小麦过敏。这些对小麦敏感的患者缺乏明确的诊断自身免疫或过敏标准,因此出现了非乳糜泻性麸质敏感的描述。临床上仅在极少数个体中可检测到,可能分别表现为肠道、肠外或神经植物性及身心症状。然而,非乳糜泻性麸质敏感必须与肠易激综合征、碳水化合物吸收不良、感染后状况和身心疾病进行严格区分。在病理生理学上,非乳糜泻性麸质敏感仍未得到很好的描述;有几种非免疫机制被认为与非乳糜泻性麸质敏感有关。这些机制包括低聚果糖和低聚半乳糖的作用、淀粉酶的胰蛋白酶抑制剂以及小麦凝集素,它们可能影响或调节肠道通透性和/或胃肠道内的非特异性免疫或效应细胞脱颗粒。此外,目前还在讨论对肠道菌群有直接或间接影响的其他代谢作用。除了主观报告的可能不同程度影响肠道、肠外和/或神经精神症状的症状变化外,一些研究表明,麸质暴露引起的不适症状几乎没有可重复性。对于非乳糜泻性麸质敏感的确切诊断,必须进行小麦或麸质的结构化(盲法)激发试验,以及在避免麸质一定时间后进行重新激发试验,以确定非乳糜泻性麸质敏感是一种持续性疾病实体。